Skip to main content
Book Chapter

Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression

Springer International Publishing, (2022), 189-191
DOI: 10.1007/978-3-030-94960-0_34
0Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The investigators conducted a multicenter open-label longitudinal study with randomized placebo-controlled double-blind maintenance phase to evaluate the effect of risperidone augmentation of citalopram for relapse prevention in older patients with antidepressant-resistant depression.

Author supplied keywords

Cite

CITATION STYLE

APA

Eichenberger, A., de Abreu, I. D., Vela, D., Tusken, M., & Camp, M. M. (2022). Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression. In Essential Reviews in Geriatric Psychiatry (pp. 189–191). Springer International Publishing. https://doi.org/10.1007/978-3-030-94960-0_34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free